2 Healthcare Stocks You Can Buy Right Now Before They Surge Even Higher

Generally, you can count on drugmakers for a steady revenue performance -- since patients need their medicines, revenue holds up well at these companies regardless of general economic conditions. But certain pharmaceutical and biotech stocks stand out from time to time, behaving more like growth players with soaring revenue and stock performance. This happens when they develop or sell a drug in a particularly high-growth area or are innovating at a rapid pace.Right now, two players fit the bill -- one is a biotech that's a leader in its specialty area and now is broadening into an area of great need, and the other is a pharma giant selling one of the world's most sought-after treatments. In fact, the treatment was on the U.S. Food and Drug Administration's (FDA) shortage list until just recently due to unrelenting demand.And these players have more catalysts ahead, making them great buys right now before they surge even higher. Let's check them out.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool